<code id='5E20D9C41D'></code><style id='5E20D9C41D'></style>
    • <acronym id='5E20D9C41D'></acronym>
      <center id='5E20D9C41D'><center id='5E20D9C41D'><tfoot id='5E20D9C41D'></tfoot></center><abbr id='5E20D9C41D'><dir id='5E20D9C41D'><tfoot id='5E20D9C41D'></tfoot><noframes id='5E20D9C41D'>

    • <optgroup id='5E20D9C41D'><strike id='5E20D9C41D'><sup id='5E20D9C41D'></sup></strike><code id='5E20D9C41D'></code></optgroup>
        1. <b id='5E20D9C41D'><label id='5E20D9C41D'><select id='5E20D9C41D'><dt id='5E20D9C41D'><span id='5E20D9C41D'></span></dt></select></label></b><u id='5E20D9C41D'></u>
          <i id='5E20D9C41D'><strike id='5E20D9C41D'><tt id='5E20D9C41D'><pre id='5E20D9C41D'></pre></tt></strike></i>

          hotspot

          hotspot

          author:focus    Page View:816
          Sammy Kimball for STAT

          Is Wegovy really a brain drug? Which Alzheimer’s disease treatment works best? And what’s the point of Threads?

          We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. Our colleague Megan Molteni joins us to explain the evolving science suggesting products like Wegovy are less weight loss drugs than treatments for human desire. We also explain why this summer is shaping up to be a pivotal moment for the treatment of Alzheimer’s and discuss our befuddlement with the latest social media platform.

          advertisement

          For more on what we cover, here’s the story on GLP-1 drugs and the brain; here’s the latest on Leqembi; here’s where you can find episodes of Color Code; and here’s where you can subscribe to the First Opinion Podcast.

          Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

          And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

          explore

          BioMarin wins approval for gene therapy to treat hemophilia A
          BioMarin wins approval for gene therapy to treat hemophilia A

          AdobeTheFoodandDrugAdministrationonThursdayapprovedagenetherapytotreatpeoplewithhemophiliaA,aninheri

          read more
          ARCH Venture Partners is raising $3 billion for a life sciences fund
          ARCH Venture Partners is raising $3 billion for a life sciences fund

          AdobeARCHVenturePartners,oneofthetopinvestorsinthebiotechecosystem,israising$3billionforanewfund.The

          read more
          Wildfire smoke exposes gaps in outdoor worker protections
          Wildfire smoke exposes gaps in outdoor worker protections

          ApersonwaitingforthesubwaywearsafilteredmaskassmokyhazefromwildfiresinCanadablanketsaneighborhoodinN

          read more

          STAT's 2023 biotech VC rankings: ARCH Venture Partners tops list

          AdobeThisarticleisadaptedfromthe2023editionofSTAT’sannualreport,“Rankingbiotech’stopventurecapitalfi